According to a report compiled by Fortune Group, Unichem Laboratories’ Q4FY13 performance was excellent. Total income grew by 26.2 per cent YoY to Rs 2,435 million on account of higher-than-expected domestic and international formulation sales. Gross margin was 60.5 per cent as the contribution from exports increased. EBITDA margin expanded Y-o-Y to 17.4 per cent. Adjusted PAT grew 33.1 per cent Y-o-Y, aided by lower tax rate and higher other income.
Domestic formulations business grew 27.8 per cent YoY in Q4FY13, higher than the 7.8 per cent growth posted by the market. International sales grew 28.7 per cent YoY, as both formulations as well as API segments posted strong growth.
EP News Bureau– Mumbai
